COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,544 Articles (22,881 medRxiv, 8,663 bioRxiv)

Most recent first Previous |  Page 615: Articles 6141-6150  | Next

A cohort study of Post COVID-19 Condition across the Beta, Delta and Omicron waves in South Africa: 6-month follow up of hospitalised and non-hospitalised participants
JASSAT, W., Mudara, C., Vika, C., Welch, R., Arendse, T., Dryden, M. T. G., Blumberg, L., Mayet, N., Tempia, S., Parker, A., Nel, J., Perumal, R., Groome, M., Conradie, F., Ndjeka, N., Sigfrid, L., Merson, L., Cohen, C.
10.1101/2022.10.31.22281748 — Posted: 2022-11-01
Phase-wise Impact Analysis of the Indian National Lockdown against COVID-19 Outcomes
Mhasawade, V., Zadey, S., Nair, A.
10.1101/2022.10.27.22281585 — Posted: 2022-11-01
An optimised method for recovery and quantification of laboratory generated SARS-CoV-2 aerosols by plaque assay.
Byrne, R. L., Gould, S., Edwards, T., Wooding, D., Atkinson, B., Moore, G., Collings, K., Boisdon, C., Maher, S., Biagini, G., Adams, E. R., Fletcher, T., Pennington, S. H.
10.1101/2022.10.31.514483 — Posted: 2022-11-01
mRNA bivalent booster enhances neutralization against BA.2.75.2 and BQ.1.1
Davis-Gardner, M. E., Lai, L., Wali, B., Samaha, H., Solis, D., Lee, M., Porter-Morrison, A., Hentenaar, I. T., Yamamoto, F., Godbole, S., Douek, D. C., Lee, F. E.-H., Rouphael, N., Moreno, A., Pinsky, B. A., Suthar, M. S.
10.1101/2022.10.31.514636 — Posted: 2022-11-01
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody to antigenically distinct omicron SARS-CoV-2 subvariants
Changrob, S., Halfmann, P. J., Liu, H., Torres, J. L., McGrath, J. J. C., Ozorowski, G., Li, L., Kuroda, M., Maemura, T., Huang, M., Wilbanks, D. G., Zheng, N.-Y., Turner, H. L., Erickson, S. A., Fu, Y., Singh, G., Krammer, F., Sather, D. N., Ward, A. B., Wilson, I. A., Kawaoka, Y., Wilson, P. C.
10.1101/2022.10.31.514592 — Posted: 2022-11-01
Negligible peptidome diversity of SARS-CoV-2 and its higher taxonomic ranks
Chong, L. C., Khan, A. M.
10.1101/2022.10.31.513750 — Posted: 2022-11-01
Evaluation of the Peterborough Public Health COVID-19 Rapid Antigen Test Self-Report Tool: Implications for COVID-19 Surveillance
Smith, E., Pigeau, C., Ahmadian-Yazdi, J., Kharbouch, M., Hoffmeyer, J., Piggott, T.
10.1101/2022.10.28.22281659 — Posted: 2022-11-01
Long-term Association between NO2 and Human Mobility: A Two-year Spatiotemporal Study during the COVID-19 Pandemic in Southeast Asia
Liu, Z., Li, Y., Law, A., Tan, J. Y. K., Chua, W., Zhu, Y., Feng, C.-C., Luo, W.
10.1101/2022.10.29.22281700 — Posted: 2022-11-01
COVID-19 primary series and booster vaccination and immune imprinting
Chemaitelly, H., Ayoub, H., Tang, P., Coyle, P., YASSINE, H. M., Althani, A., Al-Khatib, H. A., Hasan, M. R., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G., Al-Kuwari, M. G., Butt, A. A., Al-Romaihi, H. E., Al-Thani, M. H. J., Al-Khal, A., Bertollini, R., Abu-Raddad, L. J.
10.1101/2022.10.31.22281756 — Posted: 2022-11-01
Tracing the origin of SARS-CoV-2 Omicron-like Spike sequences detected in wastewater
Shafer, M. M., Gregory, D. A., Bobholz, M. J., Roguet, A., Haddock Soto, L. A., Rushford, C., Vuyk, W. C., Janssen, K. H., Ries, H. J., Pilch, H. E., Mullen, P. A., Fahney, R. B., Wei, W., Lambert, M., Wenzel, J., Halfmann, P., Kawaoka, Y., Wilson, N. A., Friedrich, T. C., Pray, I. W., Westergaard, R., O'Connor, D. H., Johnson, M.
10.1101/2022.10.28.22281553 — Posted: 2022-10-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).